Detection of Low-Level KRAS Mutations Using PNA-Mediated Asymmetric PCR Clamping and Melting Curve Analysis with Unlabeled Probes  Ji Eun Oh, Hee Sun.

Slides:



Advertisements
Similar presentations
Measurement of Relative Copy Number of CDKN2A/ARF and CDKN2B in Bladder Cancer by Real-Time Quantitative PCR and Multiplex Ligation-Dependent Probe Amplification.
Advertisements

Detection of Exon 12 Mutations in the JAK2 Gene
KRAS and BRAF Mutation Analysis in Routine Molecular Diagnostics
The Use of COLD-PCR and High-Resolution Melting Analysis Improves the Limit of Detection of KRAS and BRAF Mutations in Colorectal Cancer  Irene Mancini,
Mutant Enrichment with 3′-Modified Oligonucleotides
Simultaneous Genotyping of α-Thalassemia Deletional and Nondeletional Mutations by Real-Time PCR–Based Multicolor Melting Curve Analysis  Qiuying Huang,
Allele-Specific Polymerase Chain Reaction for the Imatinib-Resistant KIT D816V and D816F Mutations in Mastocytosis and Acute Myelogenous Leukemia  Christopher.
Sensitive Detection of KRAS Mutations in Archived Formalin-Fixed Paraffin-Embedded Tissue Using Mutant-Enriched PCR and Reverse-Hybridization  Christoph.
Todd S. Laughlin, Michael W. Becker, Jane L. Liesveld, Deborah A
KRAS and BRAF Mutation Analysis in Routine Molecular Diagnostics
Rapid Detection of the Epidermal Growth Factor Receptor Mutation in Non-Small-Cell Lung Cancer for Analysis of Acquired Resistance Using Molecular Beacons 
Suppression of Wild-Type Amplification by Selectivity Enhancing Agents in PCR Assays that Utilize SuperSelective Primers for the Detection of Rare Somatic.
Kirby Siemering, Shehnaaz S. M. Manji, Wendy M
High-Fidelity DNA Polymerase Enhances the Sensitivity of a Peptide Nucleic Acid Clamp PCR Assay for K-ras Mutations  Bjørnar Gilje, Reino Heikkilä, Satu.
Multiplex Preamplification of Serum DNA to Facilitate Reliable Detection of Extremely Rare Cancer Mutations in Circulating DNA by Digital PCR  Jennifer.
A Multiplex SNaPshot Assay as a Rapid Method for Detecting KRAS and BRAF Mutations in Advanced Colorectal Cancers  Sandrine Magnin, Erika Viel, Alice.
Detection of EGFR Mutation Status in Lung Adenocarcinoma Specimens with Different Proportions of Tumor Cells Using Two Methods of Differential Sensitivity 
Molecular Analysis of Circulating Cell-Free DNA from Lung Cancer Patients in Routine Laboratory Practice  Stephan Bartels, Sascha Persing, Britta Hasemeier,
A Melting Curve Analysis–Based PCR Assay for One-Step Genotyping of β- Thalassemia Mutations  Fu Xiong, Qiuying Huang, Xiaoyun Chen, Yuqiu Zhou, Xinhua.
Philippe Szankasi, Mohamed Jama, David W. Bahler 
A Locked Nucleic Acid Clamp-Mediated PCR Assay for Detection of a p53 Codon 249 Hotspot Mutation in Urine  Selena Y. Lin, Veerpal Dhillon, Surbhi Jain,
A Novel Targeted Approach for Noninvasive Detection of Paternally Inherited Mutations in Maternal Plasma  Jessica M.E. van den Oever, Ivonne J.H.M. van.
RET Proto-Oncogene Genotyping Using Unlabeled Probes, the Masking Technique, and Amplicon High-Resolution Melting Analysis  Rebecca L. Margraf, Rong Mao,
A Pyrosequencing-Based Assay for the Rapid Detection of IDH1 Mutations in Clinical Samples  Prashanth Setty, Jennifer Hammes, Thomas Rothämel, Valentina.
Jeung-Yeal Ahn, Katie Seo, Olga Weinberg, Scott D. Boyd, Daniel A
Ken B. Waites, Li Xiao, Vanya Paralanov, Rose M. Viscardi, John I
Simultaneous Genotyping of α-Thalassemia Deletional and Nondeletional Mutations by Real-Time PCR–Based Multicolor Melting Curve Analysis  Qiuying Huang,
Sensitive Detection of KRAS Mutations in Archived Formalin-Fixed Paraffin-Embedded Tissue Using Mutant-Enriched PCR and Reverse-Hybridization  Christoph.
Detection of KRAS and BRAF Mutations in Colorectal Carcinoma
Rapid Screening Assay for KRAS Mutations by the Modified Smart Amplification Process  Kenji Tatsumi, Yasumasa Mitani, Jun Watanabe, Hideki Takakura, Kanako.
Improved Real-Time Multiplex Polymerase Chain Reaction Detection of Methylenetetrahydrofolate Reductase (MTHFR) 677C>T and 1298A>C Polymorphisms Using.
Kyong-Ah Yoon, Sohee Park, Sang Hee Lee, Jin Hee Kim, Jin Soo Lee 
Hillary S. Sloane, James P. Landers, Kimberly A. Kelly 
Detection of Exon 12 Mutations in the JAK2 Gene
Driver Gene Mutations in Stools of Colorectal Carcinoma Patients Detected by Targeted Next-Generation Sequencing  Gemma Armengol, Virinder K. Sarhadi,
Evaluation of BRAF Mutation Testing Methodologies in Formalin-Fixed, Paraffin- Embedded Cutaneous Melanomas  Johanne Lade-Keller, Kirsten M. Rømer, Per.
Genotyping of Frequent BRCA1/2 SNPs with Unlabeled Probes
Multiplex Amplification Coupled with COLD-PCR and High Resolution Melting Enables Identification of Low-Abundance Mutations in Cancer Samples with Low.
PIK3CA Hotspot Mutation Scanning by a Novel and Highly Sensitive High-Resolution Small Amplicon Melting Analysis Method  Panagiotis A. Vorkas, Nikoleta.
KRAS Mutation The Journal of Molecular Diagnostics
A Real-Time Polymerase Chain Reaction Assay for Rapid, Sensitive, and Specific Quantification of the JAK2V617F Mutation Using a Locked Nucleic Acid-Modified.
A Multi-Site Study for Detection of the Factor V (Leiden) Mutation from Genomic DNA Using a Homogeneous Invader Microtiter Plate Fluorescence Resonance.
Absence of the Caveolin-1 P132L Mutation in Cancers of the Breast and Other Organs  Shinya Koike, Yasuhiro Kodera, Akimasa Nakao, Hiroji Iwata, Yasushi.
Development of a Quantitative Real-Time Polymerase Chain Reaction Assay for the Detection of the JAK2 V617F Mutation  Elizabeth C. Wolstencroft, Katy.
Highly Sensitive Droplet Digital PCR Method for Detection of EGFR-Activating Mutations in Plasma Cell–Free DNA from Patients with Advanced Non–Small Cell.
Sensitive and Specific KRAS Somatic Mutation Analysis on Whole-Genome Amplified DNA from Archival Tissues  Ronald van Eijk, Marjo van Puijenbroek, Amiet.
A Rapid, Sensitive Assay to Detect EGFR Mutation in Small Biopsy Specimens from Lung Cancer  Yasushi Yatabe, Toyoaki Hida, Yoshitsugu Horio, Takayuki.
A Commercial Real-Time PCR Kit Provides Greater Sensitivity than Direct Sequencing to Detect KRAS Mutations  Bárbara Angulo, Elena García-García, Rebeca.
Multiplex Amplification Coupled with COLD-PCR and High Resolution Melting Enables Identification of Low-Abundance Mutations in Cancer Samples with Low.
Larissa V. Furtado, Helmut C. Weigelin, Kojo S. J
Detection of Common Disease-Causing Mutations in Mitochondrial DNA (Mitochondrial Encephalomyopathy, Lactic Acidosis with Stroke-Like Episodes MTTL
Characterization of Aberrant Melting Peaks in Unlabeled Probe Assays
Design and Evaluation of a Real-Time PCR Assay for Quantification of JAK2 V617F and Wild-Type JAK2 Transcript Levels in the Clinical Laboratory  Jason.
Application of COLD-PCR for Improved Detection of NF2 Mosaic Mutations
Detection of the JAK2 V617F Mutation by LightCycler PCR and Probe Dissociation Analysis  Marla Lay, Rajan Mariappan, Jason Gotlib, Lisa Dietz, Siby Sebastian,
Mutation Detection of Epidermal Growth Factor Receptor and KRAS Genes Using the Smart Amplification Process Version 2 from Formalin-Fixed, Paraffin-Embedded.
Performance and Clinical Evaluation of a Sensitive Multiplex Assay for the Rapid Detection of Common NPM1 Mutations  Michael Hafez, Fei Ye, Keith Jackson,
Rapid and Sensitive Real-Time Polymerase Chain Reaction Method for Detection and Quantification of 3243A>G Mitochondrial Point Mutation  Rinki Singh,
Amplification Refractory Mutation System, a Highly Sensitive and Simple Polymerase Chain Reaction Assay, for the Detection of JAK2 V617F Mutation in Chronic.
KRAS Genotyping of Paraffin-Embedded Colorectal Cancer Tissue in Routine Diagnostics  Wilko Weichert, Christiane Schewe, Annika Lehmann, Christine Sers,
A Rapid and Reliable Test for BRCA1 and BRCA2 Founder Mutation Analysis in Paraffin Tissue Using Pyrosequencing  Liying Zhang, Tomas Kirchhoff, Cindy.
Novel Method for PIK3CA Mutation Analysis
Rapid Polymerase Chain Reaction-Based Detection of Epidermal Growth Factor Receptor Gene Mutations in Lung Adenocarcinomas  Qiulu Pan, William Pao, Marc.
Improved Detection of KIT Exon 11 Duplications in Formalin-Fixed, Paraffin-Embedded Gastrointestinal Stromal Tumors  Jerzy Lasota, Bartosz Wasag, Sonja.
Evaluation of High-Resolution Melting Analysis as a Diagnostic Tool to Detect the BRAF V600E Mutation in Colorectal Tumors  Martin Pichler, Marija Balic,
Optimized Allele-Specific Real-Time PCR Assays for the Detection of Common Mutations in KRAS and BRAF  Alois H. Lang, Heinz Drexel, Simone Geller-Rhomberg,
Steven F. Dobrowolski, Richard A. Banas, Joseph G
Comparison of Sanger Sequencing, Pyrosequencing, and Melting Curve Analysis for the Detection of KRAS Mutations  Athanasios C. Tsiatis, Alexis Norris-Kirby,
Detection of BRCA1 and BRCA2 Ashkenazi Jewish Founder Mutations in Formalin- Fixed Paraffin-Embedded Tissues Using Conventional PCR and Heteroduplex/Amplicon.
Improved Detection of the KIT D816V Mutation in Patients with Systemic Mastocytosis Using a Quantitative and Highly Sensitive Real-Time qPCR Assay  Thomas.
Presentation transcript:

Detection of Low-Level KRAS Mutations Using PNA-Mediated Asymmetric PCR Clamping and Melting Curve Analysis with Unlabeled Probes  Ji Eun Oh, Hee Sun Lim, Chang Hyeok An, Eun Goo Jeong, Ji Youn Han, Sug Hyung Lee, Nam Jin Yoo  The Journal of Molecular Diagnostics  Volume 12, Issue 4, Pages 418-424 (July 2010) DOI: 10.2353/jmoldx.2010.090146 Copyright © 2010 American Society for Investigative Pathology and Association for Molecular Pathology Terms and Conditions

Figure 1 PNA-mediated asymmetric PCR clamping system. A: Primer and probe positions. B: Point mutation: Both the sense mutant detection probe and antisense clamp probe are located on the mutation site of KRAS (c.35G>T). The sense mutant detection probes are designed to fail to bind to the antisense clamp probes because of the mismatches. C: Schematic presentation of the reactions to detect point mutations. In the amplification step, the clamp probe cannot bind to the mutation types but binds to the wild-type, resulting in preferential amplification of single-strand mutant sequences by an asymmetric PCR. In the detection step, the mutant probes bind to the single-strand mutant sequences. The signals are detected by a melting curve analysis. The Journal of Molecular Diagnostics 2010 12, 418-424DOI: (10.2353/jmoldx.2010.090146) Copyright © 2010 American Society for Investigative Pathology and Association for Molecular Pathology Terms and Conditions

Figure 2 Melting curve assay under the nonclamping condition. Melting curve analysis with DCM2 detection probe was performed under nonclamping condition with 100 ng genomic DNA of SW480 cells with KRAS mutation and K562 cells without KRAS mutation by varying the ratio of the 2 types (A, 100% wild-type, 0% mutant; B, 70% wild-type, 30% mutant; C, 80% wild-type, 20% mutant; D, 90% wild-type, 10% mutant; E, 95% wild-type, 5% mutant). WT indicates wild-type melting peak; MT, mutant melting peak. The Journal of Molecular Diagnostics 2010 12, 418-424DOI: (10.2353/jmoldx.2010.090146) Copyright © 2010 American Society for Investigative Pathology and Association for Molecular Pathology Terms and Conditions

Figure 3 Comparison of sensitivity of KRAS mutation detection between clamping and nonclamping conditions. Melting curve analysis with the DCM2 detection probe under nonclamping (blue line) and clamping (red line) conditions using 100-ng genomic DNAs, which consist of 100% wild-type DNA (A), 50% mutant DNA from SW480 cells (B), 1% mutant DNA from SW480 cells (C), and 0.1% mutant DNA from SW480 cells (D). WT indicates wild-type melting peak; MT, mutant melting peak. The Journal of Molecular Diagnostics 2010 12, 418-424DOI: (10.2353/jmoldx.2010.090146) Copyright © 2010 American Society for Investigative Pathology and Association for Molecular Pathology Terms and Conditions

Figure 4 Application of the clamping assay to cell lines and paraffin-embedded tumor tissues with different KRAS mutations. Melting curve analysis (A–E) with the DCM2 detection probe under clamping condition using 100 ng genomic DNAs with varying ratio of the mutant DNA (100% wild-type DNA, 50% mutant DNA, 1% mutant DNA, and 0.1% mutant DNA). Melting curve analysis (F–H) under clamping and nonclamping conditions with paraffin-embedded tumor tissue DNA. SW480 cells (A), A549 cells (B), MIA PaCa-2 cells (C), LS174T cells (D), SW1116 cells (E), wild-type tumor tissue (F), c.35G>T mutant tumor tissue (G), and c.35G>A mutant tumor tissue (H). Mut indicates mutant DNA; MT, mutant melting peak; WT, wild-type melting peak. The Journal of Molecular Diagnostics 2010 12, 418-424DOI: (10.2353/jmoldx.2010.090146) Copyright © 2010 American Society for Investigative Pathology and Association for Molecular Pathology Terms and Conditions